{
    "hands_on_practices": [
        {
            "introduction": "A proficient Clinical Breast Examination (CBE) is a foundational skill, where effectiveness hinges on a systematic and comprehensive technique. This exercise presents a simulated scenario of a missed lesion to deconstruct the CBE process, highlighting common pitfalls in both procedure and documentation. By analyzing these failures, you will reinforce the principles of a high-quality examination that maximizes sensitivity and ensures the creation of clear, auditable clinical records essential for patient safety and continuity of care .",
            "id": "4415259",
            "problem": "A high-fidelity simulation in an Obstetrics and Gynecology clinic evaluates a trainee’s Clinical Breast Examination (CBE) on a standardized patient. The simulator log confirms a palpable, firm, mobile lesion measuring approximately $1.8$ $\\mathrm{cm}$ located at the $10$ o’clock position, $3$ $\\mathrm{cm}$ from the nipple in the upper outer quadrant and extending toward the axillary tail of Spence. The trainee’s technique included: inspection only with arms at sides; palpation using a non-overlapping circular pattern with a single pressure depth; omission of axillary tail and regional lymph node evaluation; no supine positioning with ipsilateral arm overhead; and a total palpation time of approximately $45$ seconds per breast. Documentation consisted of a single line: “no masses palpated,” without location, size, or lymph node details.\n\nIn a process analysis meeting, the faculty ask which corrective actions best address the failures in both technique and documentation to minimize false negatives and ensure auditable, reproducible notes that support clinical decision-making and follow-up. Choose the single best option.\n\nA. Implement a standardized, comprehensive CBE protocol: perform inspection with arms at sides, arms elevated, and hands pressing on hips; palpate in the supine position with the ipsilateral arm overhead using a vertical strip method with overlapping coverage and three levels of pressure; explicitly include the axillary tail of Spence and regional nodes (axillary, supraclavicular, infraclavicular); and adopt a structured note that records clock-face location and distance from the nipple, bidimensional size in cm, consistency, mobility, associated skin/nipple changes, and node findings, with explicit negative statements when appropriate.\n\nB. Extend palpation time to at least $5$ minutes per breast but continue the current palpation pattern; refer all patients for screening ultrasound regardless of age or findings; document “breasts normal” unless a mass is visibly apparent, omitting clock-face and measurement details.\n\nC. Focus palpation on the central breast to reduce false positives; order screening mammography for all patients regardless of age or risk; document locations qualitatively (e.g., “upper outer”) without measurements or distance from nipple.\n\nD. Use only bimanual areolar compression and nipple discharge testing to enhance ductal lesion detection; omit axillary palpation to save time; document size as “pea-sized” and location as “upper outer quadrant,” without clock-face or distance metrics.\n\nE. Switch to a radial spoke palpation method limited to inner quadrants; rely on body diagram annotations alone; omit regional lymph node examination to streamline workflow.",
            "solution": "## Problem Validation\n\n### Step 1: Extract Givens\n\nThe problem statement provides the following information:\n*   **Lesion Characteristics**: A palpable, firm, mobile lesion is present.\n*   **Lesion Size**: Approximately $1.8$ $\\mathrm{cm}$.\n*   **Lesion Location**: $10$ o’clock position, $3$ $\\mathrm{cm}$ from the nipple in the upper outer quadrant, extending toward the axillary tail of Spence.\n*   **Trainee's Examination Technique**:\n    *   **Inspection**: Performed only with the patient's arms at their sides.\n    *   **Palpation Pattern**: Non-overlapping circular pattern.\n    *   **Palpation Pressure**: Single pressure depth.\n    *   **Area Examined**: Omission of axillary tail and regional lymph node evaluation.\n    *   **Patient Positioning**: No supine positioning with ipsilateral arm overhead.\n    *   **Duration**: Approximately $45$ seconds per breast.\n*   **Trainee's Documentation**: A single line entry: “no masses palpated,” with no details on location, size, or lymph node status.\n*   **Objective**: To identify the corrective actions that best address the failures in both technique and documentation to minimize false negatives and ensure auditable, reproducible notes.\n\n### Step 2: Validate Using Extracted Givens\n\n1.  **Scientific Grounding**: The problem is grounded in the principles of clinical medicine, specifically the standardized methodology for a Clinical Breast Examination (CBE). The terminology used (e.g., quadrants, clock-face location, axillary tail of Spence, palpation patterns, lymph node evaluation) is standard in obstetrics, gynecology, and oncology. The described lesion and the trainee's errors represent a realistic and common scenario in medical training and quality assessment. The goal of minimizing false negatives and improving documentation is a cornerstone of evidence-based medical practice. The problem is scientifically and factually sound.\n\n2.  **Well-Posedness**: The problem clearly defines a set of observed deficiencies in a clinical procedure and asks for the best set of corrective actions from a list of mutually exclusive options. This structure allows for a unique, optimal solution based on established clinical practice guidelines.\n\n3.  **Objectivity**: The description of the trainee's performance and the simulated lesion are factual and quantitative. The question asks for the \"best\" option, which in this context refers to the option most aligned with evidence-based standards of care, not subjective preference. The language is precise and unbiased.\n\n### Step 3: Verdict and Action\n\nThe problem statement is **valid**. It is scientifically grounded, well-posed, and objective, presenting a clear scenario for which a solution can be derived based on established medical principles. I will now proceed to the solution.\n\n## Solution Derivation\n\nThe trainee's performance exhibits multiple significant deviations from the standard of care for a Clinical Breast Examination (CBE), resulting in a false-negative finding. The goal is to identify a corrective plan that addresses all deficiencies in both technique and documentation.\n\n### Analysis of Failures:\n\n1.  **Inspection Failure**: Inspection was incomplete. Standard protocol requires inspection in multiple positions (arms at sides, arms raised overhead, and hands pressing on hips) to accentuate any skin dimpling, asymmetry, or retraction that might indicate an underlying mass. The trainee used only one position.\n2.  **Positioning Failure**: The patient was not placed in the supine position with the ipsilateral arm raised overhead. This position is critical because it flattens the breast tissue against the chest wall, making it thinner and easier to palpate systematically. Palpating a seated patient is inadequate.\n3.  **Palpation Technique Failure**:\n    *   **Pattern**: A non-overlapping circular pattern is prone to missing areas of breast tissue. The vertical strip (or \"lawnmower\") pattern is recommended by major health organizations (e.g., American College of Obstetricians and Gynecologists - ACOG) as it ensures more complete and systematic coverage.\n    *   **Pressure**: Using a single pressure depth is insufficient. A thorough CBE requires three levels of pressure (light, medium, deep) at each point to assess the full thickness of the breast tissue, from just under the skin to the chest wall.\n4.  **Scope of Examination Failure**: The omission of the axillary tail of Spence and the regional lymph nodes (axillary, supraclavicular, infraclavicular) is a critical error. A significant portion of breast tissue extends into the axilla, and this is a common location for malignancies. Furthermore, assessing regional lymph nodes is essential for staging if cancer is suspected.\n5.  **Duration Failure**: $45$ seconds is widely considered insufficient for a diligent CBE. Studies have shown a correlation between increased palpation time (typically several minutes per breast) and increased sensitivity for detecting masses.\n6.  **Documentation Failure**: The note \"no masses palpated\" is factually incorrect (a false negative) and professionally inadequate. It lacks the necessary detail to be auditable, reproducible, or useful for longitudinal care. Proper documentation, even for a negative exam, should confirm the components of the exam performed (e.g., inspection, palpation, lymph node assessment) and explicitly state the absence of masses, tenderness, skin changes, or adenopathy. For a positive finding, it must include location (quadrant and clock face), distance from nipple, size, consistency, mobility, and associated findings.\n\n### Evaluation of Options:\n\n**A. Implement a standardized, comprehensive CBE protocol: perform inspection with arms at sides, arms elevated, and hands pressing on hips; palpate in the supine position with the ipsilateral arm overhead using a vertical strip method with overlapping coverage and three levels of pressure; explicitly include the axillary tail of Spence and regional nodes (axillary, supraclavicular, infraclavicular); and adopt a structured note that records clock-face location and distance from the nipple, bidimensional size in cm, consistency, mobility, associated skin/nipple changes, and node findings, with explicit negative statements when appropriate.**\n\nThis option directly and comprehensively corrects every single identified failure:\n*   **Inspection**: Corrected by using three positions.\n*   **Positioning**: Corrected by using the supine position with arm overhead.\n*   **Palpation Technique**: Corrected by mandating the preferred vertical strip pattern, overlapping coverage, and three pressure levels.\n*   **Scope**: Corrected by explicitly including the axillary tail and regional nodes.\n*   **Documentation**: Corrected by requiring a detailed, structured, and auditable note format for both positive and negative findings.\nThis protocol represents the current evidence-based standard of care.\n\nVerdict: **Correct**\n\n**B. Extend palpation time to at least $5$ minutes per breast but continue the current palpation pattern; refer all patients for screening ultrasound regardless of age or findings; document “breasts normal” unless a mass is visibly apparent, omitting clock-face and measurement details.**\n\nThis option is deeply flawed. While extending palpation time is beneficial, it retains the suboptimal palpation pattern and fails to correct the errors in inspection, positioning, pressure, and scope. Recommending universal ultrasound screening is not evidence-based and represents a misuse of resources. The documentation standard proposed (\"breasts normal\") is grossly insufficient and fails to address the original documentation failure.\n\nVerdict: **Incorrect**\n\n**C. Focus palpation on the central breast to reduce false positives; order screening mammography for all patients regardless of age or risk; document locations qualitatively (e.g., “upper outer”) without measurements or distance from nipple.**\n\nThis option is dangerous. Focusing palpation centrally would mean ignoring the upper outer quadrant and axillary tail, where the majority of breast cancers occur. This would *increase*, not decrease, false negatives. Universal screening mammography for all ages is not the standard of care and exposes younger women to unnecessary radiation. The proposed documentation is imprecise and inadequate.\n\nVerdict: **Incorrect**\n\n**D. Use only bimanual areolar compression and nipple discharge testing to enhance ductal lesion detection; omit axillary palpation to save time; document size as “pea-sized” and location as “upper outer quadrant,” without clock-face or distance metrics.**\n\nThis option proposes a drastically incomplete examination, replacing a full CBE with a test for only one specific sign (nipple discharge). Omitting axillary palpation is a critical error. The documentation suggestions (\"pea-sized\") are subjective and non-standard. This approach would miss the vast majority of non-ductal, non-discharge-related breast lesions, like the one described in the problem.\n\nVerdict: **Incorrect**\n\n**E. Switch to a radial spoke palpation method limited to inner quadrants; rely on body diagram annotations alone; omit regional lymph node examination to streamline workflow.**\n\nThis option is also dangerously incomplete. While the radial spoke method is an acceptable palpation pattern, limiting the exam to the inner quadrants is a critical error, as it misses the most common site of cancer (upper outer quadrant). Omitting lymph node examination is also a major failure. Relying on diagrams alone is often insufficient without descriptive text.\n\nVerdict: **Incorrect**\n\n## Conclusion\nOption A is the only option that describes a comprehensive, evidence-based, and systematic approach to correcting every identified failure in the trainee's performance. It aligns perfectly with the standards for a high-quality CBE set forth by major medical and professional organizations.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Once the correct technique is mastered, the critical next step is to translate physical findings into a coherent clinical assessment and an evidence-based management plan. This problem challenges you to synthesize a constellation of CBE findings that are highly suspicious for malignancy, connecting them to their underlying pathophysiological basis. Practicing this synthesis is essential for developing the astute clinical judgment needed to estimate patient risk and urgently initiate the standard-of-care diagnostic pathway .",
            "id": "4415236",
            "problem": "A nonlactating $45$-year-old multiparous woman presents with a new breast lump she noticed $4$ weeks ago. She denies fever, trauma, or nipple discharge. On Clinical Breast Examination (CBE), there is a single palpable mass in the upper outer quadrant of the right breast measuring approximately $2$ cm in greatest dimension. The mass is hard to palpation, has an irregular surface and margins, is non-tender, and is difficult to mobilize relative to the overlying skin and underlying chest wall. With arm elevation, subtle dimpling of the overlying skin is observed consistent with skin tethering. There is no erythema or warmth. The contralateral breast is unremarkable. Axillary examination does not reveal frank fixation of nodes, though one small node feels firm.\n\nStarting from foundational anatomic and pathophysiologic principles of breast disease, synthesize the clinical examination features to estimate this patient’s malignancy risk qualitatively and identify the single most appropriate prioritized next step in management. Choose the best option.\n\nA. Reassure the patient and schedule a repeat CBE in $6$ months because the lesion is relatively small and painless\n\nB. Begin empirical oral antibiotics for suspected subclinical mastitis and reassess in $2$ weeks\n\nC. Arrange urgent triple assessment: bilateral diagnostic mammography and targeted ultrasonography with image-guided core needle biopsy, including clinical and imaging assessment of the axilla, and refer to a multidisciplinary breast clinic\n\nD. Perform clinic Fine-Needle Aspiration (FNA) of the mass and, if cytology is negative, discharge to routine screening\n\nE. Proceed directly to wide local excision of the mass without prior imaging or needle biopsy to avoid delays",
            "solution": "The user has provided a clinical problem in obstetrics and gynecology and has requested a rigorous, principle-based analysis.\n\n### Step 1: Extract Givens\n\nThe clinical data provided in the problem statement are as follows:\n-   **Patient:** A $45$-year-old nonlactating, multiparous woman.\n-   **History:** Presentation with a new breast lump noticed $4$ weeks prior. The patient denies fever, trauma, or nipple discharge.\n-   **Clinical Breast Examination (CBE) Findings:**\n    -   **Mass:** A single, palpable mass in the upper outer quadrant of the right breast.\n    -   **Size:** Approximately $2$ cm in greatest dimension.\n    -   **Palpation Characteristics:** The mass is hard, has an irregular surface and margins, is non-tender, and exhibits decreased mobility (fixation) relative to the overlying skin and underlying chest wall.\n    -   **Skin Changes:** Subtle dimpling (skin tethering) of the overlying skin is observed with arm elevation. No erythema or warmth is present.\n    -   **Contralateral Breast:** Unremarkable.\n-   **Axillary Examination:** No frank fixation of nodes, but one small node is noted to be firm on palpation.\n-   **Question:** Synthesize the clinical features to estimate malignancy risk and identify the single most appropriate prioritized next step in management, based on foundational anatomic and pathophysiologic principles.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement is evaluated for validity.\n\n1.  **Scientific Grounding:** The problem is firmly grounded in established medical science, specifically breast oncology and anatomy. The described clinical signs (hard mass, irregular margins, skin tethering, fixation, firm axillary node) are classic textbook indicators of potential breast malignancy. The underlying pathophysiology, such as tumor infiltration of Cooper's ligaments causing skin tethering, is a well-understood principle. The problem is scientifically sound.\n2.  **Well-Posedness:** The problem presents a clear, specific clinical scenario and asks for the determination of the standard-of-care management pathway. Sufficient information is provided from the physical examination to make a definitive choice about the immediate next step. A unique, standard, and meaningful solution exists within modern clinical guidelines.\n3.  **Objectivity:** The description of clinical findings is objective, using standard medical terminology (e.g., \"hard,\" \"irregular,\" \"non-tender,\" \"skin tethering\"). It is free of subjective or ambiguous language.\n\nThe problem is not scientifically unsound, non-formalizable, incomplete, contradictory, unrealistic, or ill-posed. It presents a classic and non-trivial clinical reasoning challenge.\n\n### Verdict and Action\n\nThe problem statement is **valid**. A solution will be derived.\n\n### Derivation from First Principles\n\nThe objective is to synthesize the clinical findings based on anatomy and pathophysiology to determine the most probable diagnosis and the corresponding optimal management strategy.\n\n1.  **Anatomic and Pathophysiologic Correlation:**\n    -   The breast parenchyma is supported by fibrous connective tissue septa known as **Cooper's ligaments**, which extend from the pectoral fascia to the overlying dermis.\n    -   An invasive carcinoma is characterized by disorganized cellular proliferation and invasion into surrounding stroma. This process often incites a **desmoplastic reaction**, where the body lays down dense, fibrous tissue. This reaction is responsible for the **hard** consistency and **irregular margins** of the palpable mass.\n    -   As the tumor invades and enlarges, it can entrap and shorten the Cooper's ligaments. This traction on the ligaments pulls the attached skin inward, creating the clinical sign of **skin dimpling or tethering**, which is most evident on maneuvers that stretch the ligaments, such as arm elevation.\n    -   Invasion into the deep pectoral fascia or superficially into the dermis results in **fixation** of the mass to the chest wall or skin, respectively, explaining why the mass is \"difficult to mobilize.\"\n    -   Breast cancers are typically non-inflammatory in nature, hence the characteristic **non-tender** quality and the absence of erythema or warmth, which would suggest an infectious process like mastitis.\n    -   The lymphatic drainage of the breast is primarily to the axillary lymph nodes. A **firm** axillary lymph node is highly suspicious for metastatic infiltration, where cancer cells have replaced the normal nodal architecture. The upper outer quadrant, where this mass is located, is the most common site for breast cancer, accounting for approximately $50\\%$ of cases.\n\n2.  **Qualitative Risk Synthesis:** The patient is $45$ years old, an age at which the incidence of breast cancer is significant. The constellation of findings—a new, hard, irregular, fixed mass of $2$ cm, associated with skin tethering and a firm axillary node—creates a very **high clinical suspicion for invasive breast carcinoma with likely regional lymph node metastasis**.\n\n3.  **Principles of Diagnosis and Management:** The modern standard of care for a suspicious breast lesion is the **triple assessment**, comprising:\n    i.  **Clinical Assessment:** Has been performed and is highly suspicious.\n    ii. **Radiological Imaging:** This includes both mammography and ultrasonography. Bilateral mammography is required to characterize the known lesion, identify any non-palpable disease (e.g., microcalcifications indicative of ductal carcinoma in situ [DCIS]) in either breast, and assess breast density. Targeted ultrasonography is superior for characterizing solid versus cystic lesions, defining mass margins, and is the preferred modality for guiding needle biopsy and assessing the axilla.\n    iii. **Pathological Examination:** A definitive diagnosis can only be made by obtaining a tissue sample for histological analysis. The gold standard method is a **core needle biopsy (CNB)**, typically performed under image guidance (ultrasound). CNB provides a core of tissue, allowing the pathologist to distinguish between invasive and in-situ disease, determine the histological type and grade of the cancer, and—critically—perform analysis for prognostic and predictive biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor $2$ (HER$2$). This information is essential for planning subsequent treatment (surgical, medical, or radiation).\n\n    This integrated approach has a diagnostic accuracy approaching $100\\%$. The findings guide referral to a multidisciplinary team (surgeon, radiologist, pathologist, medical oncologist, radiation oncologist) for coordinated treatment planning.\n\n### Option-by-Option Analysis\n\n**A. Reassure the patient and schedule a repeat CBE in $6$ months because the lesion is relatively small and painless**\n-   **Justification:** This action fundamentally misinterprets the clinical signs. Benign features include smoothness, mobility, and softness; this mass presents with the opposite. Pain is an unreliable symptom and is often absent in early breast cancer. A 2 cm mass is a $T_2$ lesion per the TNM staging system, not insignificant. Delaying diagnosis of a highly suspicious lesion for $6$ months would constitute a severe deviation from the standard of care and would likely allow for disease progression, worsening the patient's prognosis.\n-   **Verdict:** **Incorrect**.\n\n**B. Begin empirical oral antibiotics for suspected subclinical mastitis and reassess in $2$ weeks**\n-   **Justification:** This assumes an infectious cause. The patient has no signs of infection or inflammation (no fever, erythema, warmth, or tenderness). The mass characteristics are classic for malignancy, not an abscess or mastitis. This approach would delay the correct diagnosis without any clinical or pathophysiological basis.\n-   **Verdict:** **Incorrect**.\n\n**C. Arrange urgent triple assessment: bilateral diagnostic mammography and targeted ultrasonography with image-guided core needle biopsy, including clinical and imaging assessment of the axilla, and refer to a multidisciplinary breast clinic**\n-   **Justification:** This option perfectly aligns with the standard-of-care \"triple assessment\" derived from first principles. It recognizes the urgency, specifies the correct imaging modalities (mammography and ultrasound), identifies the gold-standard method for tissue diagnosis (image-guided core needle biopsy), includes necessary staging of the axilla, and routes the patient into the appropriate multidisciplinary care pathway. This approach ensures rapid, accurate diagnosis and facilitates optimal treatment planning.\n-   **Verdict:** **Correct**.\n\n**D. Perform clinic Fine-Needle Aspiration (FNA) of the mass and, if cytology is negative, discharge to routine screening**\n-   **Justification:** FNA provides only cytological information (individual cells), not histological architecture. It has a higher false-negative rate than CNB and cannot reliably distinguish invasive from in-situ cancer. Most importantly, discharging a patient with such highly suspicious clinical findings based on a negative FNA is unacceptable practice, as the negative result is likely due to a sampling error. The underlying high clinical suspicion mandates a more definitive test like CNB.\n-   **Verdict:** **Incorrect**.\n\n**E. Proceed directly to wide local excision of the mass without prior imaging or needle biopsy to avoid delays**\n-   **Justification:** This describes a primary excisional biopsy. This approach is obsolete and suboptimal for a lesion suspected to be malignant. Proceeding to surgery without a preoperative tissue diagnosis means some women with benign disease would undergo unnecessary surgery. For those with cancer, it prevents proper surgical planning (e.g., determining lumpectomy vs. mastectomy), precludes the standard-of-care sentinel lymph node biopsy which must be done concurrently, and eliminates the option of neoadjuvant (preoperative) systemic therapy, which is often indicated for larger or more aggressive cancers. This path leads to more, not fewer, delays and potential for suboptimal treatment.\n-   **Verdict:** **Incorrect**.",
            "answer": "$$\\boxed{C}$$"
        },
        {
            "introduction": "Beyond technique and qualitative interpretation, an expert clinician understands the quantitative power and limitations of a diagnostic test. This practice moves from physical assessment to statistical reasoning by applying Bayes' theorem to the results of a CBE. You will derive and calculate how a positive examination finding quantitatively refines the pretest probability of malignancy into a more informative post-test probability, a concept fundamental to evidence-based medicine and effective patient counseling .",
            "id": "4415359",
            "problem": "A clinician in a tertiary obstetrics and gynecology breast clinic performs a Clinical Breast Examination (CBE) on a cohort of patients. In this clinic, among patients who present with a new palpable breast finding, the pretest probability of malignancy is $0.05$. The CBE, when performed by trained examiners following a standardized protocol, has sensitivity $0.60$ and specificity $0.90$ for detecting malignancy. Consider a single patient from this cohort whose CBE is interpreted as positive.\n\nStarting from the fundamental definitions of sensitivity as $P(+|D)$, specificity as $P(-|\\bar{D})$, and the law of total probability together with Bayes’ theorem, derive the analytic expression for the post-test probability $P(D|+)$ in terms of $P(D)$, sensitivity, and specificity, without invoking any unprovided shortcut formulas. Then evaluate this expression for $P(D)=0.05$, sensitivity $=0.60$, and specificity $=0.90$.\n\nExpress your final answer for the post-test probability as a decimal number. Do not use a percentage sign.",
            "solution": "The problem asks for the derivation and calculation of the post-test probability of malignancy given a positive Clinical Breast Examination (CBE), based on fundamental principles of probability.\n\nLet $D$ be the event that a patient has malignancy (the disease is present).\nLet $\\bar{D}$ be the event that a patient does not have malignancy.\nLet $+$ be the event that the CBE result is positive.\nLet $-$ be the event that the CBE result is negative.\n\nThe information provided in the problem statement can be formalized as follows:\nThe pretest probability of malignancy, or prevalence, is $P(D) = 0.05$.\nThe sensitivity of the CBE is the probability of a positive test given that the disease is present: $P(+|D) = 0.60$.\nThe specificity of the CBE is the probability of a negative test given that the disease is absent: $P(-|\\bar{D}) = 0.90$.\n\nFrom these given probabilities, we can deduce two other probabilities that will be necessary for the derivation:\nThe probability of not having the disease is $P(\\bar{D}) = 1 - P(D) = 1 - 0.05 = 0.95$.\nThe probability of a positive test given that the disease is absent (the false positive rate) is $P(+|\\bar{D}) = 1 - P(-|\\bar{D}) = 1 - 0.90 = 0.10$.\n\nThe objective is to derive an expression for and calculate the post-test probability of malignancy given a positive test result, which is denoted by $P(D|+)$.\n\nThe derivation starts from the fundamental definition of conditional probability, which is the foundation of Bayes' theorem:\n$$P(D|+) = \\frac{P(D \\cap +)}{P(+)}$$\nwhere $P(D \\cap +)$ is the joint probability of having the disease and testing positive.\n\nThe numerator, $P(D \\cap +)$, can be re-expressed using the definition of conditional probability, $P(+|D) = \\frac{P(D \\cap +)}{P(D)}$. Rearranging this gives:\n$$P(D \\cap +) = P(+|D) P(D)$$\nThe terms on the right-hand side, $P(+|D)$ and $P(D)$, are the given sensitivity and prevalence, respectively.\n\nThe denominator, $P(+)$, is the total probability of receiving a positive test result. To evaluate this, we use the law of total probability. The sample space is partitioned by the events $D$ and $\\bar{D}$. Therefore, the event $+$ can be decomposed into two mutually exclusive events: testing positive with the disease ($+ \\cap D$) and testing positive without the disease ($+ \\cap \\bar{D}$).\n$$P(+) = P(+ \\cap D) + P(+ \\cap \\bar{D})$$\nUsing the definition of conditional probability for each term, we get:\n$$P(+) = P(+|D)P(D) + P(+|\\bar{D})P(\\bar{D})$$\n\nNow, we substitute the expanded expressions for the numerator and the denominator back into the original formula for $P(D|+)$:\n$$P(D|+) = \\frac{P(+|D)P(D)}{P(+|D)P(D) + P(+|\\bar{D})P(\\bar{D})}$$\n\nThis is the analytic expression for the post-test probability. To express it purely in terms of the given quantities (prevalence $P(D)$, sensitivity $S_e = P(+|D)$, and specificity $S_p = P(-|\\bar{D})$), we substitute $P(\\bar{D}) = 1 - P(D)$ and $P(+|\\bar{D}) = 1 - P(-|\\bar{D}) = 1 - S_p$:\n$$P(D|+) = \\frac{S_e \\cdot P(D)}{S_e \\cdot P(D) + (1 - S_p) \\cdot (1 - P(D))}$$\nThis completes the derivation as requested.\n\nThe next step is to evaluate this expression using the numerical values provided:\n$P(D) = 0.05$\n$S_e = P(+|D) = 0.60$\n$S_p = P(-|\\bar{D}) = 0.90$\n\nSubstituting these values into the derived formula:\n$$P(D|+) = \\frac{0.60 \\cdot 0.05}{0.60 \\cdot 0.05 + (1 - 0.90) \\cdot (1 - 0.05)}$$\n\nFirst, we calculate the numerator:\nNumerator $= 0.60 \\times 0.05 = 0.03$\n\nNext, we calculate the denominator. The first term in the denominator is the same as the numerator, $0.03$. The second term is:\nSecond term of denominator $= (1 - 0.90) \\times (1 - 0.05) = 0.10 \\times 0.95 = 0.095$\n\nThe total value of the denominator is the sum of these two terms:\nDenominator $= 0.03 + 0.095 = 0.125$\n\nFinally, we compute the post-test probability:\n$$P(D|+) = \\frac{0.03}{0.125}$$\nTo express this as a decimal, we perform the division:\n$$P(D|+) = \\frac{30}{125} = \\frac{6}{25} = 0.24$$\n\nThus, for a patient from this cohort with a positive CBE, the probability of having malignancy increases from a pretest probability of $0.05$ to a post-test probability of $0.24$.",
            "answer": "$$\n\\boxed{0.24}\n$$"
        }
    ]
}